REVIEW PAPER
The implication of ocular manifestation of COVID-19 for medical staff and patients – systematic review
 
More details
Hide details
1
Department of Vitreoretinal Surgery, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Małgorzata Latalska   

Department of Vitreoretinal Surgery, Medical University of Lublin, Chmielna 1, 20-079, Lublin, Poland
 
Ann Agric Environ Med. 2020;27(2):165–170
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) is a coronavirus that causes COVID-19 (coronavirus disease 2019) with mild to severe respiratory illness. It is a highly contagious disease transmitted through direct or indirect contact with infected people or contaminated surfaces, mainly through respiratory droplets, but other routes are being investigated.

Objective:
It is known that coronaviruses (CoVs) can cause a variety of ocular pathologies in animals, including conjunctivitis, anterior uveitis, retinitis, and optic neuritis, many of which are severe. However, there is no evidence of the SARS-CoV-2 presence in the eye tissue of asymptomatic patients, even if the symptomatic incidence is low. This systematic review presents updated literature on this issue.

Abbreviated description of the state of knowledge:
COVID-19 has now spread throughout the continents and poses a global threat to public health. The risk of rapidly overloading health care systems and causing substantial mortality worldwide is real. On 11 March 2020, the World Health Organization (WHO) announced coronavirus as a global pandemic. Several studies described a few cases with initial ocular symptoms followed by systemic symptoms of the disease.

Summary:
Although the frequency of transmission of SARS-CoV-2 infection through the eye is low, ocular symptoms are not uncommon in COVID-19. In some cases, eye symptoms may be the first signs of illness. This implies the need for hygienic recommendations and use of personal protective equipment (PPE) for medical staff and other services to minimize COVID-19 infection of both health-care workers and patients. A triage for ophthalmic outpatient clinic is mandatory.

 
REFERENCES (50)
1.
American Academy of Ophthalmology Coronavirus eye safety. 2020 https://www.aao.org/eye-health... (access: 2020.04.22).
 
2.
The Lancet Editorial Board. COVID-19: protecting health-care workers. Lancet. 2020; 395(10228): 922.
 
3.
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China 2019. N Engl J Med. 2020; 382: 727–733.
 
4.
CDC, WHO Important coronavirus updates for ophthalmologists https://www.aao.org/headline/a... (access 27April 2020).
 
5.
Lu J, Cui J, Qian Z, Wang Y, Zhang H, Duan Y, et al. On the origin and continuing evolution of SARS-CoV-2, National Science Review In press (2020), doi: 10.1093/nsr/nwaa036 (access: 2020.04.26).
 
6.
Habibzadeh P, Stoneman EK The Novel Coronavirus: A Bird’s Eye View, Int J Occup Environ Med. 2020; 11(2): 65–71.
 
7.
Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020. https://www.sciencedirect.com/... (access: 2020.04.27).
 
8.
Yu A, Tu R, Shao X, Pan A, Zhou K, Huang J. A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology. Eye and Vis. 2020; 7: 19 (doi.org/10.1186/s40662-020-001...) (access: 2020.04.26).
 
9.
Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020; 1–5.
 
10.
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. In press; 2020.
 
11.
Jun I, Anderson DE, Kang AE, Wang LF, Rao P, Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology In press; 2020.
 
12.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. In press; 2020.
 
13.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020 Mar 5; 382(10): 970–971 (doi: 10.1056/NEJMc2001468).
 
14.
Romano MR, Montericcio A, Montalbano C, Raimondi R, Allegrini D, Ricciardelli G, et al. Facing COVID-19 in Ophthalmology Department, Current Eye Res. 2020. DOI: 10.1080/02713683.2020.1752737 (access: 2020.04.27).
 
15.
Bonn D SARS virus in tears? Lancet Infect Dis. 2004; 4(8): 480.
 
16.
Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS, Br J Ophthalmol. 2004; 88(7): 968–969.
 
17.
Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004; 88(7): 861–863.
 
18.
America Academy of Ophthalmology, Alert: Important coronavirus updates for ophthalmologists, AAO Alerts, (2020) (access:2020.04.22).
 
19.
Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020; published online March 18. DOI: 10.1111/aos.14413.
 
20.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar; 579(7798): 270–273. DOI: 10.1038/s41586-020-2012-7.
 
21.
Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation anddiagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty 2020; 9(1): 29.
 
22.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. In press; 2020: 102433.
 
23.
Warnes SL, Little ZR, Keevil CW. Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials, mBio 2015; 6(6): e01697–15.
 
24.
Ikonen N, Savolainen-Kopra C, Enstone JE, Kulmala I, Pasanen P, Salmela A, et al. Deposition of respiratory virus pathogens on frequently touched surfaces at airports. BMC Infect Dis. 2018; 18(1): 437.
 
25.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses oninanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; 104(3): 246–251.
 
26.
Ong SWX, Tan YK, Chia PY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. Published online March 04, 2020. (doi:10.1001/jama.2020.3227).
 
27.
Sun C, Wang Y, Liu G, Liu Z. Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know. Preprints 2020, 2020030271 (doi: 10.20944/preprints202003.0271.v1).
 
28.
Cheng-wei L, Xiu-fen L, Zhi-fang J. 2019-nCoV transmission through the ocular surface must not be ignored. The Lancet 2020; 395(10224): e39 (doi.org/10.1016/S0140-6736(20)...).
 
29.
Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 534 cases of COVID19 in China: A cross-sectional study. medRxiv 2020 (doi.org/10.1101/2020.03.12.200...).
 
30.
Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019(COVID-19) in Hubei province, China. JAMA Ophthalmol. Published online March31, 2020. doi:10.1001/jamaophthalmol.2020.1294.
 
31.
Bhattacharyya A, Sarma P, Sarma B, et al. Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam. Medicine (Baltimore) 2020; 99. (DOI:10.1097/MD.0000000000018570.).
 
32.
Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, et al. Drug targets for corona virus: A systematic review. Indian J Pharmacol. 2020; 52: 56–65.
 
33.
Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol. 2020.
 
34.
Wagner J, Jan Danser AH, Derkx FH, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996; 80: 159–63.
 
35.
Savaskan E, Löffler KU, Meier F, Müller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004; 36: 312–20.
 
36.
Holappa M, Valjakka J, Vaajanen A. Angiotensin(1–7) and ACE2, “The Hot Spots” of Renin-Angiotensin System, Detected in the Human Aqueous Humor. Open Ophthalmol J. 2015; 9: 28–32.
 
37.
Määttä M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, Tuukkanen J, et al. Immunolocalization of EMMPRIN (Cd147) in the Human Eyeand Detection of Soluble Form of EMMPRIN in Ocular Fluids. Current Eye Res. 2006; 31: 917–24.
 
38.
Smith VJ, Dyrynda EA Antimicrobial proteins: From old proteins, new tricks. Mol Immunol. 2015; 68(2 Pt B): 383–398.
 
39.
Malaczewska J, Kaczorek-Lukowska E, Wojcik R, Siwicki AK. Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus. BMC Vet Res. 2019; 15(1): 318.
 
40.
Flanagan JL, Willcox MD. Role of lactoferrin in the tear film. Biochimie 2009; 91(1): 35–43.
 
41.
Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection Ann Intern Med. 2020; [Epub ahead of print 17 April 2020]. doi: https://doi.org/10.7326/M20-11... (access: 2020.04.27).
 
42.
Lin C, Ye R, Xia YL. A meta-analysis to evaluate the effectiveness of real time PCR for diagnosing novel coronavirus infections. Genet Mol Res. 2015; 14(4): 15634–15641. https://doi.org/10.4238/2015 (access:2020.04.22).
 
43.
Xu L, Zhang, X,Song W, Sun B, Mu J, Wang B, Wang Z, Cao Y, Dong X. Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China. doi: https://doi.org/10.1101/2020.0... (access:2020.04.24).
 
44.
World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance, 2020.
 
45.
Acta Ophthalmologica Polonica 2020; 122,1: 11–13, doi: https://doi.org/10.5114/ko.202... (access:2020.04.22).
 
46.
Wan KH, Huang SS, Young A, Lam DSC. Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19), doi: 10.1111/aos.14438 (access:2020.04.26).
 
47.
Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, et al. The infection evidence of SARS-COV-2 in ocular Surface:a single-center cross-sectional study. Preprints from med Rxiv and bioRxiv. doi: https://doi.org/10.1101/2020.0... (access:2020.04.22).
 
48.
Deng C, Yang Y, Chen H, et al. Ocular Dectection of SARS-CoV-2 in 114 Cases of COVID-19 Pneumonia in Wuhan, China: An Observational Study. Rochester, NY: Social Science Research Network, 2020 https://papers.ssrn.com/abstra... (access: 2020.04.22).
 
49.
Dai X. Peking University Hospital Wang Guangfa disclosed treatment status on Weibo and suspected infection without wearing goggles. Jan 22, 2020. http://www.bjnews.com.cn/news/... (access:2020.04.24).
 
50.
Jones L, Walsh K, Willcox M, Morgan P, Nichols J. The COVID-19 pandemic: Important considerations for contact lens practitioners. Contact Lens and Anterior Eye, https://doi.org/10.1016/j.clae... (access: 2020.04.22).
 
eISSN:1898-2263
ISSN:1232-1966